Back
34
Day Range
$18.17
$20.43
52-Week Range
$14.09
$21.22
Volume
24
50D / 200D Avg
$18.17
/
$19.03
Prev Close
$18.17
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.1 | 0.2 |
| P/B | 0.0 | 3.0 |
| ROE % | 10.6 | 3.5 |
| Net Margin % | 5.2 | 3.8 |
| Rev Growth 5Y % | 17.5 | 9.7 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$195.59
$191.17 – $199.53
|
1.26T | 1 |
| FY2029 |
$185.85
$181.64 – $189.59
|
1.23T | 1 |
| FY2028 |
$162.15
$158.48 – $165.42
|
1.21T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | $42.39 | $0.26 | -99.4% |
| 2025-11-12 | $0.22 | $0.23 | +4.0% |
| 2025-08-11 | $0.24 | $0.22 | -6.7% |
| 2025-05-08 | $0.19 | $0.23 | +22.6% |
| 2025-02-12 | $0.25 | $0.26 | +1.9% |
| 2024-11-14 | $0.24 | $0.22 | -7.4% |
| 2024-08-13 | $0.19 | $0.17 | -9.4% |
| 2024-05-10 | $0.17 | $0.16 | -4.2% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
0.31%
Growth (3Y)
-17.59%
Growth (5Y)
-13.59%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Jun 01, 2026 | $0.17 | 1.80% |
| Sep 30, 2025 | Dec 02, 2025 | $0.16 | 1.66% |
| Mar 31, 2025 | Jun 23, 2025 | $0.15 | 2.14% |
| Sep 30, 2024 | Dec 03, 2024 | $0.15 | 1.63% |
| Mar 28, 2024 | Jun 24, 2024 | $0.13 | 1.42% |
| Sep 28, 2023 | Dec 04, 2023 | $0.33 | 1.81% |
| Mar 30, 2023 | Jun 26, 2023 | $0.34 | 1.65% |
| Sep 29, 2022 | Dec 02, 2022 | $0.28 | 1.51% |
| Mar 30, 2022 | Jun 29, 2022 | $0.29 | 1.48% |
| Sep 29, 2021 | Dec 02, 2021 | $0.31 | 1.59% |
| Mar 30, 2021 | Jun 30, 2021 | $0.32 | 1.41% |
| Sep 29, 2020 | Dec 02, 2020 | $0.33 | 1.61% |
| Mar 30, 2020 | Jun 29, 2020 | $0.32 | 1.59% |
| Sep 27, 2019 | Dec 03, 2019 | $0.32 | 1.57% |
| Mar 27, 2019 | Jun 28, 2019 | $0.32 | 1.43% |
| Sep 26, 2018 | Dec 04, 2018 | $0.27 | 1.34% |
| Mar 28, 2018 | Jun 29, 2018 | $0.28 | 1.24% |
| Sep 27, 2017 | Dec 05, 2017 | $0.44 | 1.48% |
| Mar 29, 2017 | Jun 30, 2017 | $0.45 | 1.82% |
| Sep 28, 2016 | Dec 05, 2016 | $0.45 | 1.63% |
Key Takeaways
Revenue grew 17.50% annually over 5 years — strong growth
ROE of 10.56% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 67.01B in free cash flow
P/E of 0.13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.68%
Growth
Revenue Growth (5Y)
17.50%
Revenue (1Y)3.82%
Earnings (1Y)4.45%
FCF Growth (3Y)19.01%
Quality
Return on Equity
10.56%
ROIC11.77%
Net Margin5.15%
Op. Margin7.73%
Safety
Debt / Equity
0.00
Current Ratio2.24
Interest Coverage1282.53
Valuation
P/E Ratio
0.13
Forward P/E0.13
P/B Ratio0.01
EV/EBITDA-1.25
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.82% | Revenue Growth (3Y) | 5.64% |
| Earnings Growth (1Y) | 4.45% | Earnings Growth (3Y) | 16.13% |
| Revenue Growth (5Y) | 17.50% | Earnings Growth (5Y) | 26.13% |
| Profitability | |||
| Revenue (TTM) | 1.06T | Net Income (TTM) | 54.68B |
| ROE | 10.56% | ROA | 7.67% |
| Gross Margin | 35.06% | Operating Margin | 7.73% |
| Net Margin | 5.15% | Free Cash Flow (TTM) | 67.01B |
| ROIC | 11.77% | FCF Growth (3Y) | 19.01% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.24 |
| Interest Coverage | 1282.53 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.31% |
| Dividend Growth (3Y) | -17.59% | Dividend Growth (5Y) | -13.59% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.13 | Forward P/E | 0.13 |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | 2.32 | Forward PEG | N/A |
| EV/EBITDA | -1.25 | Fwd EV/EBITDA | -0.66 |
| Forward P/S | 0.01 | Fwd Earnings Yield | 769.23% |
| FCF Yield | 926.84% | ||
| Market Cap | 7.23B | Enterprise Value | -102.31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.06T | 1.02T | 951.25B | 729.97B | 556.91B |
| Net Income | 54.68B | 52.35B | 40.55B | 34.38B | 21.60B |
| EPS (Diluted) | 133.81 | 125.27 | 95.99 | 93.78 | 70.12 |
| Gross Profit | 372.24B | 331.80B | 329.32B | 240.30B | 182.10B |
| Operating Income | 82.08B | 75.71B | 62.28B | 41.41B | 31.53B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 712.78B | 724.75B | 688.13B | 656.74B | 368.92B |
| Total Liabilities | 191.28B | 209.57B | 205.42B | 192.40B | 122.46B |
| Shareholders' Equity | 520.80B | 514.73B | 482.47B | 464.32B | 246.46B |
| Total Debt | 2.21B | 20.66B | 21.41B | 22.92B | 23.70B |
| Cash & Equivalents | 111.75B | 117.72B | 95.22B | 74.52B | 38.52B |
| Current Assets | 364.32B | 370.80B | 329.81B | 304.39B | 175.70B |
| Current Liabilities | 162.64B | 179.43B | 153.27B | 142.45B | 84.89B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#576 of 826
Recent Activity
Exited
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026